Abstract
A 44-year-old female patient with no known history
 of chronic disease was admitted to the emergency
 room with tachycardia and shortness of breath after
 covid-19 vaccine (Pfizer Biontech). The blood pressure
 of the patient who was consulted to cardiology: 80/40
 mmHg. Echocardiography (ECHO): Ejection Fraction
 was 65%, pericardial effusion (PE) was present at
 its widest point, 5 cm encircling the heart, collapsing
 the right heart cavities in diastole, forming the clinic
 of tamponade. Emergency pericardiocentesis was
 applied to the patient. Pericardial fluid content of the
 patient was serous. The patient, whose clinical stability
 was stabilized after pericardiocentesis, was followed in
 the coronary intensive care unit. No pericardial effusion
 was observed in the control echo duringfollow-up.
 Thepatient's PCR results were negative. The patient
 was discharged with cardiology outpatient control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
